- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 26th, 2011
A synthetic vaccine based on nanotechnology holds out the promise of halting auto-immune diseases such as Crohn's and rheumatoid arthritis, it was reported today.
Early research has shown that the molecular principle behind the approach works, at least in mice.
Scientists are excited by the findings which hold out the prospect of new treatments for a broad range of conditions. The research could also lead to new ways of tackling the spread of cancer.
However, much more work is needed before experts can be sure the therapy is safe for humans.
|Related News Press|
News and information
Graphene makes rubber more rubbery May 23rd, 2016
Programmable materials find strength in molecular repetition May 23rd, 2016
Electronic device detects molecules linked to cancer, Alzheimer's and Parkinson's: An inexpensive portable biosensor has been developed by researchers at Brazil's National Nanotechnology Laboratory with FAPESP's support May 20th, 2016